Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.
Pediatric pulmonology(2023)
Abstract
Standardization of CPGs may improve clinical decision making around use of palivizumab in high-risk infants.
MoreTranslated text
Key words
Palivizumab,RSV,guideline,infants,prophylaxis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined